Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial

Kurt Huber, David Holmes Jr, Arnoud van't Hof, Gilles Montalescot, Philip Aylward, Amadeo Betriu, Petr Widimsky, Cynthia Westerhout, Christopher Granger, Paul Armstrong

    Research output: Contribution to journalArticlepeer-review

    61 Citations (Scopus)

    Fingerprint Dive into the research topics of 'Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences